NCT03138928View on ClinicalTrials.gov

An Innovation in Glaucoma Surgery: XEN45 Gel Stent Implantation

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2017

Conditions
Glaucoma Eye
Interventions
DEVICE

XEN45 gel stent implantation in glaucoma surgery

The XEN gel stent (Allergan, Dublin, Ireland) is a recently developed, permanent, ab interno collagen implant that reduces IOP by draining aqueous fluid from the anterior chamber into the subconjunctival space

All Listed Sponsors
lead

Trakya University

OTHER

NCT03138928 - An Innovation in Glaucoma Surgery: XEN45 Gel Stent Implantation | Biotech Hunter | Biotech Hunter